NFE2L2 and hepatocellular carcinoma: Similar results were observed in primary cardiomyocytes upon SF treatment, and by SF and AITC treatment in models of hepatoma and fibroblasts, all of which induced Glo1 activity to lower reactive carbonyl levels through Nrf2 [120,121].